conference logo
 
Programme  Titles  Presenters  Topics 
OS7.2 - The effect of PBDE and PCBs on children - children's health oral session 3
Friday 28 August 2009, 08:30 - 10:00
Theatre B005
Chair: Gayle Windham and Marc-André Verner
OS7.2.1 Maternal PBDE Exposure and Time to Pregnancy
Kim Harley*1, Amy Marks1, Jonathan Chevrier1, Andreas Sjodin2, Asa Bradman1, Brenda Eskenazi1
1University of California, United States, 2Centers for Disease Control and Prevention, United States
OS7.2.2 Associations Between Maternal PBDE Serum Concentrations and Birth Weight and Duration of Gestation.
Jonathan Chevrier*1, Kim Harley1, Asa Bradman1, Andreas Sjodin2, Brenda Eskenazi1
1UC Berkeley, United States, 2Centers for Disease Control and Prevention, United States
OS7.2.3 Associations Between Maternal PBDE Serum Concentrations and Child Neurodevelopment in the CHAMACOS Cohort.
Brenda Eskenazi1, Amy Marks1, Jonathan Chevrier*1, Kim Harley1, Asa Bradman1, Andreas Sjodin2
1University of California, Berkeley, United States, 2Centers for Disease Control and Prevention, United States
OS7.2.5 Impairment of Infant Behaviour by Polychlorinated Biphenyls (PCBs): Physiologically-Based Pharmacokinetic (PBPK) Modeling Reveals a Critical Time Window for Postnatal Exposure
Marc-André Verner*1, Pierrich Plusquellec2, Gina Muckle2, Pierre Ayotte2, Éric Dewailly2, Joseph L. Jacobson3, Sandra W. Jacobson3, Michel Charbonneau4, Sami Haddad1
1Département des sciences biologiques, TOXEN, Université du Québec à Montréal, Canada, 2Centre de recherche du CHUQ-CHUL, Université Laval, Canada, 3Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, United States, 4INRS-Institut Armand-Frappier, Université du Québec, Canada